These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 17940077

  • 1. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.
    Gotoh M, Takiuchi H, Kawabe S, Ohta S, Kii T, Kuwakado S, Katsu K.
    Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077
    [Abstract] [Full Text] [Related]

  • 2. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.
    Samejima R, Kitajima Y, Yunotani S, Miyazaki K.
    Anticancer Res; 1999 Sep; 19(6C):5515-21. PubMed ID: 10697609
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens.
    Kii T, Takiuchi H, Kawabe S, Gotoh M, Ohta S, Tanaka T, Kuwakado S, Nishitani H, Katsu K.
    Jpn J Clin Oncol; 2007 Aug; 37(8):583-9. PubMed ID: 17709606
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H, Natsugoe S, Matsumoto M, Yokomakura N, Uchikado Y, Takatori H, Ishigami S, Takao S, Aikou T.
    J Surg Oncol; 2005 Jul 01; 91(1):84-9. PubMed ID: 15999354
    [Abstract] [Full Text] [Related]

  • 5. CYFRA21-1 and CEA are useful markers for predicting the sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma.
    Yi Y, Li B, Wang Z, Sun H, Gong H, Zhang Z.
    Biomarkers; 2009 Nov 01; 14(7):480-5. PubMed ID: 19863186
    [Abstract] [Full Text] [Related]

  • 6. Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy.
    Hironaka S, Hasebe T, Kamijo T, Ohtsu A, Boku N, Yoshida S, Saitoh H, Ochiai A.
    Clin Cancer Res; 2002 Jan 01; 8(1):124-30. PubMed ID: 11801548
    [Abstract] [Full Text] [Related]

  • 7. Response to definitive chemoradiotherapy and survival in patients with an oesophageal adenocarcinoma versus squamous cell carcinoma: a matched-pair analysis.
    Tougeron D, Di Fiore F, Hamidou H, Rigal O, Paillot B, Michel P.
    Oncology; 2007 Jan 01; 73(5-6):328-34. PubMed ID: 18497505
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK, Chiu PW, Leung SF, Cheung KY, Chan AC, Au-Yeung AC, Griffith JF, Chung SS, Ng EK.
    Ann Surg Oncol; 2008 Feb 01; 15(2):576-82. PubMed ID: 18057993
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer.
    Duong C, Greenawalt DM, Kowalczyk A, Ciavarella ML, Raskutti G, Murray WK, Phillips WA, Thomas RJ.
    Ann Surg Oncol; 2007 Dec 01; 14(12):3602-9. PubMed ID: 17896157
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. p53, epidermal growth factor receptor and proliferating cell nuclear antigen in laryngeal squamous cell carcinoma are not predictive markers for the effect of adjuvant radiotherapy.
    Jiang H, Yang BB.
    Acta Otolaryngol; 2009 Jan 01; 129(1):101-7. PubMed ID: 18607952
    [Abstract] [Full Text] [Related]

  • 18. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
    Koike R, Nishimura Y, Nakamatsu K, Kanamori S, Shibata T.
    Int J Radiat Oncol Biol Phys; 2008 Apr 01; 70(5):1418-22. PubMed ID: 18234437
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report.
    Fujiwara Y, Kamikonya N, Inoue T, Koishi K, Yoshikawa R, Nakao K, Yagyu R, Nishiwaki M, Fujiwara M, Kojima S, Nakagawa K, Yamamura T.
    Oncol Rep; 2005 Nov 01; 14(5):1177-82. PubMed ID: 16211282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.